The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2026 | Managing hematological malignancies in the Middle East: insights & challenges
Osama Alsmadi, PhD, King Hussein Cancer Center, Amman, Jordan, discusses the challenges of managing hematological malignancies in the Middle East, highlighting limited access to CAR T-cell therapies, inadequate research, and late diagnosis. Dr Alsmadi notes that the high cost of CAR T-cell therapy is a significant burden, although some countries in the region offer subsidized access through government or insurance coverage. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
